Medicine
Pioglitazone 30 mg tablet
Pioglitazone 30 mg tablet is a generic prescription medicine for oral use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Pioglitazone
- Brand
- Sold under the generic name
- Strength
- 30 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 500 tablets, 3 blister pack, 30 tablets and 64 more
- Manufacturers
- Aurobindo PharmaIndiaMacleods PharmaceuticalsIndiaUnichem LaboratoriesIndiaA-S Medication SolutionsBryant Ranch PrepackNuCare Pharmaceuticals,IncGsmsRising Pharma HoldingsSolco HealthcareTeva Pharmaceuticals20 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Keep container tightly closed, and protect from light, moisture and humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BG03 Pioglitazone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 February 2013
- Identifiers
- RxCUI 312440, 312441, 317573DailyMed set ID 41a9586c-8768-4fc3-bb78-e6d98b09030b, af863b9e-9646-3b1e-e053-2995a90ab93a, 31619517-a590-408a-ae9e-76c99f0a0a1d +26NDC 50090-7846, 68071-2264, 76385-179 +26Application ANDA200268, ANDA202467, ANDA210165 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 20 labelers. The register lists 67 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 tablet in 1 bottle | 65862-513-05 | Aurobindo PharmaIndia | 13 February 2013 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 65862-513-10 | Aurobindo PharmaIndia | 13 February 2013 |
| 30 tablet in 1 bottle | 65862-513-30 | Aurobindo PharmaIndia | 13 February 2013 |
| 90 tablet in 1 bottle | 65862-513-90 | Aurobindo PharmaIndia | 14 June 2019 |
| 30 tablet in 1 bottle | 33342-055-07 | Macleods PharmaceuticalsIndia | 14 February 2013 |
| 90 tablet in 1 bottle | 33342-055-10 | Macleods PharmaceuticalsIndia | 14 February 2013 |
| 100 tablet in 1 box, unit-dose | 33342-055-12 | Macleods PharmaceuticalsIndia | 14 February 2013 |
| 500 tablet in 1 bottle | 33342-055-15 | Macleods PharmaceuticalsIndia | 14 February 2013 |
| 1000 tablet in 1 bottle | 76385-179-10 | Unichem LaboratoriesIndia | 25 June 2026 |
| 30 tablet in 1 bottle | 76385-179-30 | Unichem LaboratoriesIndia | 25 June 2026 |
| 500 tablet in 1 bottle | 76385-179-50 | Unichem LaboratoriesIndia | 25 June 2026 |
| 90 tablet in 1 bottle | 76385-179-90 | Unichem LaboratoriesIndia | 25 June 2026 |
| 30 tablet in 1 bottle | 62135-805-30 | Chartwell RX | 22 August 2024 |
| 90 tablet in 1 bottle | 62135-805-90 | Chartwell RX | 22 August 2024 |
| 500 tablet in 1 bottle | 84677-027-05 | Gsms | 20 June 2026 |
| 30 tablet in 1 bottle | 84677-027-30 | Gsms | 20 June 2026 |
| 90 tablet in 1 bottle | 84677-027-90 | Gsms | 20 June 2026 |
| 500 tablet in 1 bottle | 57237-220-05 | Rising Pharma Holdings | 13 February 2013 |
| 30 tablet in 1 bottle | 57237-220-30 | Rising Pharma Holdings | 13 February 2013 |
| 90 tablet in 1 bottle | 57237-220-90 | Rising Pharma Holdings | 12 June 2019 |
| 30 tablet in 1 bottle | 43547-427-03 | Solco Healthcare | 20 May 2018 |
| 90 tablet in 1 bottle | 43547-427-09 | Solco Healthcare | 20 May 2018 |
| 500 tablet in 1 bottle | 43547-427-50 | Solco Healthcare | 20 May 2018 |
| 500 tablet in 1 bottle | 0093-7272-05 | Teva Pharmaceuticals | 4 February 2015 |
| 30 tablet in 1 bottle | 0093-7272-56 | Teva Pharmaceuticals | 22 April 2015 |
| 90 tablet in 1 bottle | 0093-7272-98 | Teva Pharmaceuticals | 3 June 2015 |
| 30 tablet in 1 bottle | 50090-6393-0 | A-S Medication Solutions | 10 March 2023 |
| 90 tablet in 1 bottle | 50090-6393-1 | A-S Medication Solutions | 10 March 2023 |
| 30 tablet in 1 bottle | 50090-6873-0 | A-S Medication Solutions | 4 December 2023 |
| 90 tablet in 1 bottle | 50090-6873-1 | A-S Medication Solutions | 4 December 2023 |
| 90 tablet in 1 bottle | 50090-6874-0 | A-S Medication Solutions | 4 December 2023 |
| 90 tablet in 1 bottle | 50090-7846-0 | A-S Medication Solutions | 30 December 2025 |
| 30 tablet in 1 bottle | 68071-2264-3 | NuCare Pharmaceuticals,Inc | 17 September 2020 |
| 30 tablet in 1 bottle | 68071-2373-3 | NuCare Pharmaceuticals,Inc | 19 March 2021 |
| 30 tablet in 1 bottle | 68071-4964-3 | NuCare Pharmaceuticals,Inc | 10 July 2019 |
| 120 tablet in 1 bottle | 68071-5210-1 | NuCare Pharmaceuticals,Inc | 17 March 2020 |
| 30 tablet in 1 bottle | 71335-1298-1 | Bryant Ranch Prepack | 18 September 2019 |
| 60 tablet in 1 bottle | 71335-1298-2 | Bryant Ranch Prepack | 27 June 2025 |
| 90 tablet in 1 bottle | 71335-1298-3 | Bryant Ranch Prepack | 12 August 2019 |
| 180 tablet in 1 bottle | 71335-1298-4 | Bryant Ranch Prepack | 27 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Pioglitazone 30 mg tablet.
Other strengths and forms of Pioglitazone
Clinical summary
Pioglitazone is a peroxisome proliferator receptor alpha agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings. MedsAcross supplies Pioglitazone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PioglitazoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Actos prescribing information (Takeda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Actos: European public assessment report (EPAR) · European Medicines Agency
- Pioglitazone Accord: European public assessment report (EPAR) · European Medicines Agency
Need Pioglitazone 30 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.